The Eynsham Medical Group is a research active practice and is part of the Thames Valley and South Midlands Clinical Research Network [National Institute for Health Research]. We actively enrol patients into studies looking for ways to improve health and treatments. Dr Ian Binnian acts as Principal Investigator, and practice nurses Leanda Rankin and Janice Williams are our specialist research nurses.
We work with academic and commercial institutions (such as Oxford, Southampton and Keele Universities, and Abbott Ltd pharmaceutical company) for medical research purposes. Your consent will be sought before enrolment in any study; however, if you never wish your data to be used for the purpose of research you may opt out either by clicking on the following link www.nhs.uk/your-nhs-data-matters/manage-your-choice or by contacting the NHS Digital Contact Centre on 0300 303 5678.
Sometimes we are asked for disease-based information for research purposes, and anonymised/pseudo-anonymised population data is requested. We contribute anonymised data to CPRD (Clinical Practice Research Datalink) for public health research, Qresearch, GPES /compulsory data collection during pandemic], RCGP RSC [Royal College of General Practitioners Research Surveillance Centre].
Individual patients cannot be identified from this information, and we would not seek an individual’s consent for these purposes. Pseudo-anonymised data is provided to IQVIA for medication and disease pattern research; however, if you have chosen to opt out of your data being used for research through the National Data Opt Out, your choice will be respected and your date will not be used for research.
If you would like to take part in any of our studies or find out more about them please book a telephone consultation with our research nurses, Janice Williams or Leanda Rankin.
PRINCIPLE Covid-19 Study
Eynsham Medical Group are delighted to be one of 400+ GP practices recruiting to the nationwide PRINCIPLE study looking at pre-hospital treatments for Covid-19 infection.
The trial is for all those over the age of 64 years, or over the age of 50 years who have a medical risk factor [including high blood pressure].
All recruits will get a swab test for Covid-19 virus. You can become involved even if you have not yet spoken to your GP or contacted 111.
If you experience a continuous cough and/or a high temperature and have had it for less than 15 days, please see our link to the PRINCIPLE website.
BEST3 study is published in the Lancet!
On behalf of the entire study team I am writing to thank you for very much your involvement in the BEST 3 trial.
You will be pleased to know that we recruited over 13,000 participants with heartburn or acid reflux symptoms from GP surgeries across England to this trial [38 from Eynsham and Long Hanborough surgeries] . The aim was to assess the small capsule sponge device called the CytospongeTM to detect patients who might be at future risk of cancer of the oesophagus. The study was a great success and we identified a number of individuals who will now have follow-up for Barrett’s oesophagus and who in some cases received treatment. The results are published today in The Lancet.